MFMichal Fried

Michal Fried

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Michal Fried has a total of 156 co-authors. Here are the top co-authors by number of shared publications:

  • Alassane Dicko

    Malaria Research and Training Center, University of Sciences, Techniques, and Technologies of Bamako, Bamako, Mali

    19 shared publications
  • Almahamoudou Mahamar

    Malaria Research and Training Center, University of Sciences, Techniques, and Technologies of Bamako, Bamako, Mali

    17 shared publications
  • Oumar Attaher

    Malaria Research and Training Center, University of Sciences, Techniques, and Technologies of Bamako, Bamako, Mali

    16 shared publications
  • Patrick E. Duffy

    Pathogenesis and Immunity Section, Laboratory of Malaria Immunology and Vaccinology (LMIV), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, United States

    14 shared publications
  • Amadou Barry

    Malaria Research and Training Center, University of Sciences, Techniques, and Technologies of Bamako, Bamako, Mali

    13 shared publications
  • Patrick E. Duffy

    Laboratory of Malaria Immunology and Vaccinology, NIAID/NIH, 29 Lincoln Drive, Building 29B, Bethesda, MD 20892-2903, USA

    13 shared publications

Latest Publications

  • Open Access

    Antibody levels to variant and conserved Plasmodium falciparum antigens predict reduction in parasite burden in Malian children

    by Delesa Damena, Lauren Dang, Amadou Barry, Jonathan P. Renn, Santara Gaoussou, Almahamoudou Mahamar, Oumar Attaher, Djibrilla Issiaka, Robert D. Morrison, Santosh A. Misal, et al.

    Background: Proteins expressed on the surface of Plasmodium falciparum -infected erythrocytes (IEs) are targets of immunity. Previous studies described that IEs from young children are more readily recognized than IEs from older children. Here, we aimed to identify targets of naturally acquired antibodies that may play a role in protection from malaria. Methods: We applied immunoprecipitation followed by mass spectrometry (IP-MS) using plasma samples from susceptible and semi-immune children. We then investigated whether 1) antibody levels to membrane-associated proteins identified by IP-MS, or 2) PfEMP1s expressed in IEs of young children predict reduction in malaria disease. Results: Significant reduction in risk of high parasite density infection was predicted by high antibody levels to DBLγ11 [OR (95%CI): 0.74 (0.63-0.86)] and DBLζ5 [0.80 (0.69-0.93)], as well as two Plasmodium helical interspersed subtelomeric proteins: PF3D7_0201600 [0.81 (0.70-0.94)] and PF3D7_0532300 [0.79 (0.68-0.92)]. Opsonic phagocytosis of DBLγ11 and DBLζ5 coated beads was significantly higher in plasma samples with antibody levels at the top tertile compared to those from lower tertiles (p2 = 0.61 (p2 = 0.49 (p<0.001) for DBLζ5 and DBLγ11, respectively. Conclusions: The study showed that high antibody levels against four proteins significantly reduced the odds of high parasite burden in future infections. Our functional study suggests that opsonic phagocytosis may mediate reduction in parasite density by antibodies to DBLγ11 and DBLζ5.


  • Open Access

    Identification of Plasmodium falciparum VAR2CSA peptides differentially recognized by IgG of multigravidae through epitope excision

    by Santosh A. Misal, Jonathan P. Renn, Robert D. Morrison, Matthew V. Cowles, Almahamoudou Mahamar, Oumar Attaher, Alassane Dicko, Patrick E. Duffy, Michal Fried

    Background: Placental malaria is associated with adverse outcomes for both mothers and their newborn children. During pregnancy, Plasmodium falciparum –infected erythrocytes (IEs) that surface-express VAR2CSA can bind chondroitin sulfate (CSA) in intervillous spaces and sequester in the placenta. Women acquire antibodies to VAR2CSA during their first pregnancy, but functional antibodies that block IE adhesion and are associated with improved outcomes develop over 2-3 pregnancies. Currently, VAR2CSA is the leading pregnancy malaria vaccine candidate. Methods: To identify and quantify epitopes differentially recognized by IgG of multigravidae that acquired anti-adhesion antibodies compared to primigravidae that did not, we applied epitope excision and multiplex isobaric labeling to quantify epitope recognition by naturally acquired antibodies. Results: While primigravidae and multigravidae IgG reacted similarly to most epitopes, multigravidae IgG differentially recognized (Log2 fold change > 1, p < 0.05) ten epitopes conserved across multiple VAR2CSA alleles. Conclusion: Knowledge of VAR2CSA epitopes preferentially recognized by immune multigravidae will be valuable for designing a VAR2CSA subunit vaccine.


  • Open Access

    Preterm Birth and Malaria Susceptibility in Offspring of Uninfected Multigravid Women

    by Amadou Barry, Lauren Dang, Youssoufa Sidibe, Djibrilla Issiaka, Santara Gaoussou, Zonghui Hu, Yahia Dicko, Almahamoudou Mahamar, Oumar Attaher, Bacary S. Diarra, et al.

    Importance: Pregnancy malaria (PM) is associated with adverse pregnancy outcomes such as stillbirth, early neonatal death, preterm delivery (PTD), and low birthweight. PM also increases the risk of malaria infection in infants. However, it is unknown whether PTD modifies the risk of malaria infection during early childhood.Objective: To investigate the association of PM and PTD with child susceptibility to malaria infection and disease.Design, Setting, and Participants: Pregnant women were enrolled between November 23, 2010, and December 9, 2014, into an observational longitudinal cohort study of mother-child pairs in Ouélessébougou, Mali, an area of high seasonal malaria transmission. Follow-up was completed through pregnancy. Children were enrolled at birth and followed up from January 21, 2011, to July 31, 2016, for as long as 5 years with monthly clinical visits during the malaria transmission season and every 2 months during the dry season. Data were analyzed from November 4, 2024, to July 15, 2025.Exposure: PM and PTD.Main Outcomes and Measures: Study end points included Plasmodium falciparum infection, clinical malaria, and severe malaria infections. Malaria diagnosis and clinical data were collected during scheduled examinations and unscheduled sick visits. Cox proportional hazards models were used to analyze whether hazards of first malaria infection and first clinical malaria infection were associated with PM and PTD. Associations between the incidence rate of parasitemia and risk factors (eg, maternal infection history, PTD) were estimated using negative binomial models. Cox proportional hazards and negative binomial models with an interaction term among PTD, pregnancy malaria, and gravidity were used to evaluate associations within strata of the 3 covariates.Results: In 1679 children included in adjusted models (848 female [50.5%] and 831 male [49.5%]), 760 (45.3%) were born during the malaria transmission season and 96 (5.7%) were born preterm. Children were followed up for a mean (SD) of 25.8 (16.1) months. PM was associated with an increased hazard of first malaria infection and first clinical malaria infection in children of women of all gravidities, while PTD (vs full-term delivery) was associated with increased hazard of first malaria infection (hazard ratio, 1.76; 95% CI, 1.05-2.95; P = .03) in offspring of multigravid women only. Further, the hazard ratio of first parasitemia for preterm compared with full-term offspring was 2.17 (95% CI, 1.25-3.75; P = .006) and 3.63 (95% CI, 1.90-5.93; P < .001) in offspring of uninfected secundigravida and multigravida women, respectively. The parasitemia infection incidence rate ratio for PTD was 2.74 (95% CI, 1.80-4.18) in offspring of uninfected multigravida women.Conclusions and Relevance: In this cohort study of young children, the association between PTD and the hazard of malaria varied based on maternal gravidity and maternal infection history during pregnancy. This information could be used to evaluate the health effects of active monitoring of P falciparum infection or adherence to malaria chemoprevention in children born preterm.


  • Open Access

    A novel locus in CSMD1 gene is associated with increased susceptibility to severe malaria in Malian children

    by Delesa Damena, Amadou Barry, Robert Morrison, Santara Gaoussou, Almahamoudou Mahamar, Oumar Attaher, Djibrilla Issiaka, Yahia Dicko, Alassane Dicko, Patrick Duffy, et al.

    Background: Plasmodium falciparum malaria is still a leading cause of child mortality in sub-Saharan Africa. The clinical manifestations of malaria range from asymptomatic infection to severe disease. The variation in clinical presentation is partly attributed to host genetic factors with estimated narrow-sense heritability of 23%. Here, we investigate the associations between candidate gene polymorphisms and the likelihood of severe malaria (SM) in a cohort of Malian children.Methods: Based on our previous genome-wide association studies (GWAS) analysis, candidate genes were selected for in-depth analysis using several criteria including gene-level GWAS scores, functional overlap with malaria pathogenesis, and evidence of association with protection or susceptibility to other infectious or inflammatory diseases. Single Nucleotide Polymorphisms (SNPs) residing within these genes were selected mainly based on p-values from previous severe malaria susceptibility GWAS studies and minor allele frequency (MAF) in West African populations.Results: Of 182 candidate genes reported in our previous study, 11 genes and 22 SNPs residing in these genes were selected. The selected SNPs were genotyped using KASP technology in 477 DNA samples (87 SM and 390 controls). Logistic regression analysis revealed that a common intron variant, rs13340578 in CUB and Sushi Multi Domain (CSMD1) gene, is associated with increased odds of SM in recessive mode of inheritance (MAF = 0.42, OR = 1.8, 95% CI = [1.78, 1.84], p = 0.029). The SNP is in linkage disequilibrium (LD) with multiple variants with regulatory features.Conclusion: Taken together, the current study showed that an intron variant rs13340578, residing in CSMD1 gene, is associated with increased susceptibility to malaria. This finding suggests that modified regulation of complement may contribute to malaria disease severity. Further studies are needed to identify the causal variants and the underlying molecular mechanisms.


  • Open Access

    Acquisition of antibodies that block Plasmodium falciparum adhesion to placental receptor chondroitin sulfate A with increasing gravidity in Malian women

    by Almahamoudou Mahamar, Moussa Traore, Bruce Swihart, Oumar Attaher, Bacary Soumana Diarra, Gaoussou Santara, Djibrilla Issiaka, Amadou Barry, Youssoufa Sidibé, Yahia T. Dicko, et al.

    In malaria-endemic areas, pregnant women are more susceptible to Plasmodium falciparum infection, especially primigravidae. During pregnancy, parasites sequester in the placenta and bind to the receptor chondroitin sulfate (CSA). This unique adhesion is mediated by the parasite protein VAR2CSA expressed on the surface of infected erythrocytes (IE). Placental malaria is associated with poor pregnancy outcomes including perinatal mortality, preterm delivery, small for gestational age (SGA) and low birthweight deliveries. Over successive pregnancies, women acquire functional antibodies that inhibit IE adhesion to CSA. Here, we examine the development of anti-adhesion activity and the breadth of anti-adhesion activity as a function of number of previous pregnancies, using samples collected from pregnant women living in an area with high seasonal malaria transmission. Women reached plateau levels of anti-adhesion activity and breadth of anti-adhesion activity after 5 pregnancies. We related the level of anti-adhesion activity and reactivity with surface IE to SGA 19/232 pregnancies resulted in SGA, and report that an increase of 10% in median anti-adhesion activity reduced the odds of SGA by 13% and this relationship approached significance. Further, at an anti-adhesion activity level of 43.7%, an increase of 10% in the breadth of activity significantly reduced the odds of SGA by 21.5%. Antibodies that recognize IE surface increased over successive pregnancies, but were not associated with a reduction in SGA. These results can serve as a guideline for assessing vaccine candidates aiming to reduce poor pregnancy outcomes associated with placental malaria.


  • Open Access

    Higher platelet counts and platelet factors are associated with a reduction in Plasmodium falciparum parasite density in young Malian children

    by Oumar Attaher, Bruce Swihart, Lauren Dang, Gaoussou Santara, Almahamoudou Mahamar, Sekouba Keita, Adama Dembele, Bacary Soumana Diarra, Djibrilla Issiaka, Amadou Barry, et al.


  • Open Access

    Pregnancy outcomes in a malaria-exposed Malian cohort of women of child-bearing age

    by Santara Gaoussou, Oumar Attaher, Bruce Swihart, Moussa Traore, Soumaila Diarra, Ibrahim H. Soumbounou, Oulematou Ndiaye, Djibrilla Issiaka, Robert Morrison, Almahamoudou Mahamar, et al.

    In Sub-Saharan Africa, malaria continues to be associated with adverse pregnancy outcomes including stillbirth, early neonatal death, preterm delivery, and low birth weight. Current preventive measures are insufficient and new interventions are urgently needed. However, before such interventions can be tested in pregnant women, background information on pregnancy outcomes in this target population must be collected. We conducted an observational study in Ouélessébougou, Mali, a malaria-endemic area where first antenatal visit commonly occurs during the second trimester of pregnancy, hindering calculation of miscarriage rate in the population. To accurately determine the rate of miscarriage, 799 non-pregnant women of child-bearing age were enrolled and surveyed via monthly follow up visits that included pregnancy tests. Out of 505 women that completed the study, 364 became pregnant and 358 pregnancies were analyzed: 43 (12%) resulted in miscarriage, 28 (65.1%) occurred during the first trimester of pregnancy. We also determined rates of stillbirth, neonatal death, preterm delivery, and small for gestational age. The results showed high rate of miscarriage during the first trimester and established a basis to evaluate new interventions to prevent pregnancy malaria. This survey design enabled identification of first trimester miscarriages that are often missed by studies conducted in antenatal clinics.Clinical trial registration: [https://clinicaltrials.gov/], identifier [NCT0297 4608].


  • Open Access

    Natural History of Malaria Infections During Early Childhood in Twins

    by Bronner P Gonçalves, Raúl Pérez-Caballero, Amadou Barry, Santara Gaoussou, Alexandra Lewin, Djibrilla Issiaka, Sekouba Keita, Bacary S Diarra, Almahamoudou Mahamar, Oumar Attaher, et al.

    Background: The frequency and clinical presentation of malaria infections show marked heterogeneity in epidemiological studies. However, deeper understanding of this variability is hampered by the difficulty in quantifying all relevant factors. Here, we report the history of malaria infections in twins, who are exposed to the same in utero milieu, share genetic factors, and are similarly exposed to vectors. Methods: Data were obtained from a Malian longitudinal birth cohort. Samples from 25 twin pairs were examined for malaria infection and antibody responses. Bayesian models were developed for the number of infections during follow-up. Results: In 16 of 25 pairs, both children were infected and often developed symptoms. In 8 of 25 pairs, only 1 twin was infected, but usually only once or twice. Statistical models suggest that this pattern is not inconsistent with twin siblings having the same underlying infection rate. In a pair with discordant hemoglobin genotype, parasite densities were consistently lower in the child with hemoglobin AS, but antibody levels were similar. Conclusions: By using a novel design, we describe residual variation in malaria phenotypes in naturally matched children and confirm the important role of environmental factors, as suggested by the between-twin pair heterogeneity in malaria history.


  • Open Access

    Plasma biomarkers of hemoglobin loss in Plasmodium falciparum–infected children identified by quantitative proteomics

    by Almahamoudou Mahamar, Patricia A. Gonzales Hurtado, Robert Morrison, Rachel Boone, Oumar Attaher, Bacary S. Diarra, Santara Gaoussou, Djibrilla Issiaka, Alassane Dicko, Patrick E. Duffy, et al.

    Anemia is common among young children infected with Plasmodium falciparum and severe malarial anemia (SMA) is a major cause of their mortality. Two major mechanisms cause malarial anemia: hemolysis of uninfected as well as infected erythrocytes and insufficient erythropoiesis. In a longitudinal birth cohort in Mali, we commonly observed marked hemoglobin reductions during P falciparum infections with a small proportion that progressed to SMA. We sought biomarkers of these processes using quantitative proteomic analysis on plasma samples from 9 P falciparum-infected children, comparing those with reduced hemoglobin (with or without SMA) vs those with stable hemoglobin. We identified higher plasma levels of circulating 20S proteasome and lower insulin-like growth factor-1 (IGF-1) levels in children with reduced hemoglobin. We confirmed these findings in independent enzyme-linked immunosorbent assay-based validation studies of subsets of children from the same cohort (20S proteasome, N = 71; IGF-1, N = 78). We speculate that circulating 20S proteasome plays a role in digesting erythrocyte membrane proteins modified by oxidative stress, resulting in hemolysis, whereas decreased IGF-1, a critical factor for erythroid maturation, might contribute to insufficient erythropoiesis. Quantitative plasma proteomics identified soluble mediators that may contribute to the major mechanisms underlying malarial anemia. This study was registered at www.clinicaltrials.gov as #NCT01168271.


  • Open Access

    A newly characterized malaria antigen on erythrocyte and merozoite surfaces induces parasite inhibitory antibodies

    by Ian C. Michelow, Sangshin Park, Shu-Whei Tsai, Bonnie Rayta, Charisse Flerida A. Pasaje, Sara Nelson, Angela M. Early, Anne P. Frosch, George Ayodo, Dipak K. Raj, et al.

    We previously identified a Plasmodium falciparum (Pf) protein of unknown function encoded by a single-copy gene, PF3D7_1134300, as a target of antibodies in plasma of Tanzanian children in a whole-proteome differential screen. Here we characterize this protein as a blood-stage antigen that localizes to the surface membranes of both parasitized erythrocytes and merozoites, hence its designation as Pf erythrocyte membrane and merozoite antigen 1 (PfEMMA1). Mouse anti-PfEMMA1 antisera and affinity-purified human anti-PfEMMA1 antibodies inhibited growth of P. falciparum strains by up to 68% in growth inhibition assays. Following challenge with uniformly fatal Plasmodium berghei (Pb) ANKA, up to 40% of mice immunized with recombinant PbEMMA1 self-cured, and median survival of lethally infected mice was up to 2.6-fold longer than controls (21 vs. 8 d, P = 0.005). Furthermore, high levels of naturally acquired human anti-PfEMMA1 antibodies were associated with a 46% decrease in parasitemia over 2.5 yr of follow-up of Tanzanian children. Together, these findings suggest that antibodies to PfEMMA1 mediate protection against malaria.